Medtech titan Covidien (NYSE:COV) is breaching new ground in home care with its ZephyrLIFE remote monitoring platform, agreeing to license the technology to healthcare solutions company Geneia.
Zephyr Technologies
Making the business case for connectivity: mHealth, wearables and unlocking data
By Jeff Champagne, MPR Product Development
From Star Trek to Minority Report, technology predictions have often led to advances in technology.
However, in order for this new technology to move from the celluloid screen to our homes and everyday lives there needs to be a catalyst. In the case of wearable devices for health monitoring and medical applications, that catalyst is the growing cost of healthcare. This pain point for the economy is driving a collision between medical device and technology companies.
Confirmed: Covidien acquires Zephyr’s wearable monitors
Medtronic’s Ishrak: Europe slow to adopt renal denervation | Wall Street Beat
French breast implant scandal chief released from jail | MassDevice.com On Call
MASSDEVICE ON CALL — French medical device CEO Jean-Claude Mas was freed from prison and is awaiting trial after he admitted that he allowed his company to use substandard silicone in breast implants.